Selective small-molecule inhibition of an RNA structural element
The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Riboswitches are non-coding RNA structures located in messenger RNAs that bind endogenous ligands, such as a specific metabolite or ion, to regulate gene expression. As such, riboswitches serve as a novel, yet largely unexploited, class of emerging drug targets. Demonstrating this potential, however, has proven difficult and is restricted to structurally similar antimetabolites and semi-synthetic analogues of their cognate ligand, thus greatly restricting the chemical space and selectivity sought for such inhibitors. Here we report the discovery and characterization of ribocil, a highly selective chemical modulator of bacterial riboflavin riboswitches, which was identified in a phenotypic screen and acts as a structurally distinct synthetic mimic of the natural ligand, flavin mononucleotide, to repress riboswitch-mediated ribB gene expression and inhibit bacterial cell growth. Our findings indicate that non-coding RNA structural elements may be more broadly targeted by synthetic small molecules than previously expected.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ribocil binding inhibits translation of ribB transcript in E. coli, inducing cell death by riboflavin starvation.”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [123]
In the citing paper
“a high throughput screening of small molecules recently identified an inhibitor of riboflavin synthesis, called “ribocil”, that targets a regulatory non-coding region (i.e. riboswitch) in the mRNA of a synthase involved in the pathway, ribB [123].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [123]
In the citing paper
“ribocil administration, although only at high concentrations, significantly reduced bacterial burden in a mouse model of systemic infection with E. coli”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [123]
Citations
Cites
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
Kabsch, W. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909047337 · Cited by 16,463
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products
Datsenko, K. A., & Wanner, B. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120163297 · Cited by 14,782
Construction of Escherichia coli K‐12 in‐frame, single‐gene knockout mutants: the Keio collection
Baba, T., Ara, T., Hasegawa, M., Takai, Y., Okumura, Y., Baba, M., Datsenko, K. A., Tomita, M., Wanner, B. L., & Mori, H. (2006) · Molecular Systems Biology · doi:10.1038/msb4100050 · Cited by 7,858
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2012) · International Tables for Crystallography · doi:10.1107/97809553602060000865 · Cited by 7,334
Landscape of transcription in human cells
Djebali, S., Davis, C. A., Merkel, A., Dobin, A., Lassmann, T., Mortazavi, A., Tanzer, A., Lagarde, J., Lin, W., Schlesinger, F., et al. (2012) · Nature · doi:10.1038/nature11233 · Cited by 5,187
Self-citationBad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
How good are my data and what is the resolution?
Evans, P. R., & Murshudov, G. N. (2013) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444913000061 · Cited by 4,697
Functional Characterization of the S. cerevisiae Genome by Gene Deletion and Parallel Analysis
Winzeler, E. A., Shoemaker, D. D., Astromoff, A., Liang, H., Anderson, K., Andre, B., Bangham, R., Benito, R., Boeke, J. D., Bussey, H., et al. (1999) · Science · doi:10.1126/science.285.5429.901 · Cited by 3,953
The Transcriptional Landscape of the Mammalian Genome
Carninci, P., Kasukawa, T., Katayama, S., Gough, J., Frith, M. C., Maeda, N., Oyama, R., Ravasi, T., Lenhard, B., Wells, C., et al. (2005) · Science · doi:10.1126/science.1112014 · Cited by 3,499
Data processing and analysis with the autoPROC toolbox
Vonrhein, C., Flensburg, C., Keller, P., Sharff, A., Smart, O., Paciorek, W., Womack, T., & Bricogne, G. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444911007773 · Cited by 2,029
How were new medicines discovered?
Swinney, D. C., & Anthony, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3480 · Cited by 1,812
Lu, X.-J. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg680 · Cited by 1,660
Clostridium difficile Infection
Leffler, D. A., & Lamont, J. T. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1403772 · Cited by 1,450
Rfam 12.0: updates to the RNA families database
Nawrocki, E. P., Burge, S. W., Bateman, A., Daub, J., Eberhardt, R. Y., Eddy, S. R., Floden, E. W., Gardner, P. P., Jones, T. A., Tate, J., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1063 · Cited by 1,071
Serganov, A., & Nudler, E. (2013) · Cell · doi:10.1016/j.cell.2012.12.024 · Cited by 1,013
Vaguine, A. A., Richelle, J., & Wodak, S. J. (1999) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998006684 · Cited by 886
REGULATION OF BACTERIAL GENE EXPRESSION BY RIBOSWITCHES
Winkler, W. C., & Breaker, R. R. (2005) · Annual Review of Microbiology · doi:10.1146/annurev.micro.59.030804.121336 · Cited by 727
An mRNA structure that controls gene expression by binding FMN
Winkler, W. C., Cohen-Chalamish, S., & Breaker, R. R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212628899 · Cited by 696
Sensing Small Molecules by Nascent RNA
Mironov, A. S., Gusarov, I., Rafikov, R., Lopez, L. E., Shatalin, K., Kreneva, R. A., Perumov, D. A., & Nudler, E. (2002) · Cell · doi:10.1016/s0092-8674(02)01134-0 · Cited by 682
Antibiotics: Actions, Origins, Resistance
Walsh, C. T. (2003) · Medical Entomology and Zoology · Cited by 675
Antibiotics: Actions, Origins, Resistance
Walsh, C. (2003) · Wiley eBooks · doi:10.1128/9781555817886 · Cited by 633
Phenotypic screening in cancer drug discovery — past, present and future
Moffat, J. G., Rudolph, J., & Bailey, D. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4366 · Cited by 507
The Speed of RNA Transcription and Metabolite Binding Kinetics Operate an FMN Riboswitch
Wickiser, J. K., Winkler, W. C., Breaker, R. R., & Crothers, D. M. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.02.032 · Cited by 483
Riboswitches as antibacterial drug targets
Blount, K. F., & Breaker, R. R. (2006) · Nature Biotechnology · doi:10.1038/nbt1268 · Cited by 468
Vitreschak, A. G. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf433 · Cited by 326
Coenzyme recognition and gene regulation by a flavin mononucleotide riboswitch
Serganov, A., Huang, L., & Patel, D. J. (2009) · Nature · doi:10.1038/nature07642 · Cited by 289
Recent Advances in Developing Small Molecules Targeting RNA
Guan, L., & Disney, M. D. (2012) · ACS Chemical Biology · doi:10.1021/cb200447r · Cited by 280
Thiamine Pyrophosphate Riboswitches Are Targets for the Antimicrobial Compound Pyrithiamine
Sudarsan, N., Cohen-Chalamish, S., Nakamura, S., Emilsson, G. M., & Breaker, R. R. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.10.007 · Cited by 267
Lee, E. R., Blount, K. F., & Breaker, R. R. (2009) · RNA Biology · doi:10.4161/rna.6.2.7727 · Cited by 235
A conserved RNA structure element involved in the regulation of bacterial riboflavin synthesis genes
Gelfand, M. (1999) · Trends in Genetics · doi:10.1016/s0168-9525(99)01856-9 · Cited by 205
Novel Riboswitch Ligand Analogs as Selective Inhibitors of Guanine-Related Metabolic Pathways
Mulhbacher, J., Brouillette, E., Allard, M., Fortier, L.-C., Malouin, F., & Lafontaine, D. A. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000865 · Cited by 175
Discovery of a Small Molecule that Blocks Wall Teichoic Acid Biosynthesis in Staphylococcus aureus
Swoboda, J. G., Meredith, T. C., Campbell, J., Brown, S., Suzuki, T., Bollenbach, T., Malhowski, A. J., Kishony, R., Gilmore, M. S., & Walker, S. (2009) · ACS Chemical Biology · doi:10.1021/cb900151k · Cited by 151
Self-citationMack, M., van Loon, A. P. G. M., & Hohmann, H. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.4.950-955.1998 · Cited by 151
Discovery of Wall Teichoic Acid Inhibitors as Potential Anti-MRSA β-Lactam Combination Agents
Wang, H., Gill, C. J., Lee, S. H., Mann, P., Zuck, P., Meredith, T. C., Murgolo, N., She, X., Kales, S., Liang, L., et al. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.11.013 · Cited by 136
Self-citationMetabolic suppression identifies new antibacterial inhibitors under nutrient limitation
Zlitni, S., Ferruccio, L. F., & Brown, E. D. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1361 · Cited by 124
Determination of Selectivity and Efficacy of Fatty Acid Synthesis Inhibitors
Kodali, S., Galgoci, A. M., Young, K., Painter, R. E., Silver, L. L., Herath, K. B., Singh, S. B., Cully, D. F., Barrett, J. F., Schmatz, D. M., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406848200 · Cited by 121
Self-citationVicens, Q., Mondragón, E., & Batey, R. T. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr565 · Cited by 116
Ott, E., Stolz, J., & Mack, M. (2009) · RNA Biology · doi:10.4161/rna.6.3.8342 · Cited by 104
Unexpected versatility in bacterial riboswitches
Mellin, J. R., & Cossart, P. (2015) · Trends in Genetics · doi:10.1016/j.tig.2015.01.005 · Cited by 101
ROSEOFLAVIN, A NEW ANTIMICROBIAL PIGMENT FROM STREPTOMYCES
Otani, S., Takatsu, M., Nakano, M., Kasai, S., Miura, R., & Matsui, K. (1974) · The Journal of Antibiotics · doi:10.7164/antibiotics.27.88 · Cited by 93
The promise of riboswitches as potential antibacterial drug targets
Weinberg, C. E., Schüller, A., & Mayer, G. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.09.002 · Cited by 85
Flavoproteins Are Potential Targets for the Antibiotic Roseoflavin in Escherichia coli
Langer, S., Hashimoto, M., Hobl, B., Mathes, T., & Mack, M. (2013) · Journal of Bacteriology · doi:10.1128/jb.00646-13 · Cited by 82
Pedrolli, D. B., Matern, A., Wang, J., Ester, M., Siedler, K., Breaker, R. R., & Mack, M. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks616 · Cited by 79
Pedrolli, D. B., Langer, S., Hobl, B., Schwarz, J., Hashimoto, M., & Mack, M. (2015) · FEBS Journal · doi:10.1111/febs.13226 · Cited by 78
Riboflavin operon of Bacillus subtilis: unusual symmetric arrangement of the regulatory region
Kil, Y., Mironovi, V. N., Gorishin, I. Y., Kreneva, R. A., & Perumov, D. A. (1992) · Molecular and General Genetics MGG · doi:10.1007/bf00265448 · Cited by 67
Eberhardt, S., Richter, G., Gimbel, W., Werner, T., & Bacher, A. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0712r.x · Cited by 61
Balibar, C. J., Hollis‐Symynkywicz, M., & Tao, J. (2011) · Journal of Bacteriology · doi:10.1128/jb.00334-11 · Cited by 54
Self-citationPedrolli, D. B., Nakanishi, S., Barile, M., Mansurova, M., Carmona, E. C., Lux, A., Gärtner, W., & Mack, M. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.08.029 · Cited by 51
Letter: Roseoflavin, a new antimicrobial pigment from Streptomyces.
Otani, S., Takatsu, M., Nakano, M., Kasai, S., & Miura, R. (1974) · PubMed · Cited by 51
Riboflavin Analogs as Antiinfectives: Occurrence, Mode of Action, Metabolism and Resistance
Pedrolli, D. B., Jankowitsch, F., Schwarz, J., Langer, S., Nakanishi, S., Frei, E., & Mack, M. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319140006 · Cited by 45
Langer, S., Nakanishi, S., Mathes, T., Knaus, T., Binter, A., Macheroux, P., Mase, T., Miyakawa, T., Tanokura, M., & Mack, M. (2013) · Biochemistry · doi:10.1021/bi400348d · Cited by 42
Tuning Riboswitch‐Mediated Gene Regulation by Rational Control of Aptamer Ligand Binding Properties
Rode, A. B., Endoh, T., & Sugimoto, N. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201407385 · Cited by 38
(Dis)similar Analogues of Riboswitch Metabolites as Antibacterial Lead Compounds
Matzner, D., & Mayer, G. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm500868e · Cited by 32
Research works printed but not linked: 2
- Kodali, S. et al. Determination of selectivity and efficacy of fatty acid synthesis inhibitors. J. Biol. Chem. 280, 1669–1677 (2005) · DOI
- Bricogne, G. et al. BUSTER version 2.11.5 http://www.globalphasing.com (2014)
Cited by
Antibiotic-Induced Changes in the Intestinal Microbiota and Disease
Becattini, S., Taur, Y., & Pamer, E. G. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.04.003 · Cited by 901
“Moreover, a high-throughput screening of small molecules recently identified an inhibitor of riboflavin synthesis, ‘ribocil’, that targets a regulatory non-coding region (i.e., riboswitch) in the mRNA for a synthase involved in the pathway, RibB [123].”
BackgroundInfluentialPrinciples for targeting RNA with drug-like small molecules
Warner, K. D., Hajdin, C. E., & Weeks, K. M. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.93 · Cited by 749
Therapeutic Targeting of Long Non-Coding RNAs in Cancer
Arun, G., Diermeier, S. D., & Spector, D. L. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.01.001 · Cited by 611
Targeting RNA structures with small molecules
Childs-Disney, J. L., Yang, X., Gibaut, Q. M. R., Tong, Y., Batey, R. T., & Disney, M. D. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00521-4 · Cited by 587
RNA Structural Dynamics As Captured by Molecular Simulations: A Comprehensive Overview
Šponer, J., Bussi, G., Krepl, M., Banáš, P., Bottaro, S., Cunha, R. A., Gil-Ley, A., Pinamonti, G., Poblete, S., Jurečka, P., et al. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00427 · Cited by 599
“Richard Andre ́ Cunha (1989) received his undergraduate degree in”
Background
Metadata
- Authors
- Howe, J. A., Wang, H., Fischmann, T. O., Balibar, C. J., Xiao, L., Galgoci, A. M., Malinverni, J. C., Mayhood, T., Villafania, A., Nahvi, A., Murgolo, N., Barbieri, C. M., Mann, P. A., Carr, D., Xia, E., Zuck, P., Riley, D., Painter, R. E., Walker, S. S., Sherborne, B., de Jesus, R., Pan, W., Plotkin, M. A., Wu, J., Rindgen, D., Cummings, J., Garlisi, C. G., Zhang, R., Sheth, P. R., Gill, C. J., Tang, H., & Roemer, T.
- Affiliations
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Corresponding author
- Roemer, Terry
- ORCID
- Venue
- Nature
- Published
- 2015-09-30
- Volume
- 526
- Issue
- 7575
- Pages
- 672-677
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1931081986
- Cited by
- 407
- References
- 55
- Citations by year
- 2026: 15 · 2025: 40 · 2024: 43 · 2023: 34 · 2022: 38 · 2021: 35 · 2020: 39 · 2019: 43 · 2018: 42 · 2017: 40 · 2016: 35 · 2015: 2
- FWCI
- 17.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Institute of Microbiology, Chinese Academy of Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Keywords
- riboswitches, flavin mononucleotide, non-coding RNA, riboflavin biosynthesis, antibiotic discovery, phenotypic screening
- MeSH terms
- Animals, Bacteria, Base Sequence, Escherichia coli Infections, Female, Flavin Mononucleotide, Heat-Shock Proteins, Ligands, Mice, Inbred DBA, Models, Molecular, Molecular Sequence Data, Pyrimidines, Riboflavin, RNA, Bacterial, Substrate Specificity, Reproducibility of Results, Gene Expression Regulation, Bacterial, Crystallography, X-Ray, Intramolecular Transferases, Escherichia coli Proteins, Mice, Aptamers, Nucleotide, Riboswitch
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.